Benzinga | May 6, 2021 06:53AM EDT

Epizyme Q1 EPS $(0.69) Misses $(0.58) Estimate, Sales $7.60M Beat $6.56M Estimate

Epizyme (NASDAQ:EPZM) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate of $(0.58) by 18.97 percent. This is a 35.29 percent decrease over losses of $(0.51) per share from the same period last year. The company reported quarterly sales of $7.60 million which beat the analyst consensus estimate of $6.56 million by 15.85 percent. This is a 461.30 percent increase over sales of $1.35 million the same period last year.